Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Chembiochem : a European Journal of Chemical Biology|January 16, 2019
Direct Imaging of Protein-Specific Methylation in Mammalian CellsFranziska Doll, Raphael R Steimbach, Andreas Zumbusch
The Journal of Organic Chemistry|December 31, 2020
A Validated "Pool and Split" Approach to Screening and Optimization of Copper-Catalyzed C-N Cross-Coupling ReactionsRaphael R Steimbach, Philipp Kollmus, Marco Santagostino
Methods in Enzymology|May 17, 2025
TR-FRET assay for profiling HDAC10 inhibitors and PROTACsKim Remans, Peter Sehr, Raphael R Steimbach, et al.
ACS Chemical Biology|July 14, 2020
Structural Basis for the Selective Inhibition of HDAC10, the Cytosolic Polyamine DeacetylaseCorey J Herbst-Gervasoni, Raphael R Steimbach, Michael Morgen, et al.
Angewandte Chemie (International Ed. in English)|May 4, 2022
Commonly Used Alkylating Agents Limit Persulfide Detection by Converting Protein Persulfides into ThioethersDanny Schilling, Uladzimir Barayeu, Raphael R Steimbach, et al.
The Journal of Biological Chemistry|August 21, 2022
Histone deacetylase-10 liberates spermidine to support polyamine homeostasis and tumor cell growthTracy Murray Stewart, Jackson R Foley, Cassandra E Holbert, et al.
Nature Communications|June 15, 2023
Chemoproteomic target deconvolution reveals Histone Deacetylases as targets of (R)-lipoic acidSeverin Lechner, Raphael R Steimbach, Longlong Wang, et al.
European Journal of Medicinal Chemistry|September 3, 2023
Tetrahydro-β-carboline derivatives as potent histone deacetylase 6 inhibitors with broad-spectrum antiproliferative activityXin Chen, Jiayun Wang, Peng Zhao, et al.
European Journal of Medicinal Chemistry|December 23, 2019
Novel 2, 5-diketopiperazine derivatives as potent selective histone deacetylase 6 inhibitors: Rational design, synthesis and antiproliferative activityXin Chen, Xinyang Chen, Raphael R Steimbach, et al.
European Journal of Medicinal Chemistry|June 26, 2024
Multimechanism biological profiling of tetrahydro-β-carboline analogues as selective HDAC6 inhibitors for the treatment of Alzheimer's diseaseTing Liang, Shiru Liu, Baiyun Dang, et al.
Pageof 2